Pharmabiz

MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026

MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026: New York Monday, April 6 ...
Pharmabiz

Trialt and Viedoc partner to deliver smarter, faster clinical trial outcomes through connected data and biometrics

Trialt and Viedoc partner to deliver smarter, faster clinical trial outcomes through connected data and biometrics: Needham, Massachusetts Monday, April 6, 2026, 18:00 Hrs [IST] T ...
Pharmabiz

Transgene and NEC Bio ink agreement to prepare the next steps of the development of TG4050 in head and neck cancer

Transgene and NEC Bio ink agreement to prepare the next steps of the development of TG4050 in head and neck cancer: Strasbourg, France Monday, April 6, 2026, 17:00 Hrs [IST] Trans ...
Pharmabiz

Sir Ganga Ram Hospital launches dialysis centre in Gurgaon to expand access to dialysis care

Sir Ganga Ram Hospital has announced the launch of the Sir Ganga Ram Dialysis Centre at M2K Shopping Plaza, Sector 51, Gurgaon, marking a significant step towards expanding access to advanced dialysis ...
Pharmabiz

Kindeva commemorates 70 years of pressurized metered dose inhaler as inventors inducted into the ‘national inventors hall of fame’

Kindeva, a global contract development and manufacturing organization and drug delivery innovator, commemorates its 70 years, since the invention of the pressurized metered dose inhaler (pMDI), a ...
Pharmabiz

Akebia Therapeutics appoints biopharmaceutical leader Philip Vickers to its board of directors

Akebia Therapeutics appoints biopharmaceutical leader Philip Vickers to its board of directors: Cambridge, Massachusetts Monday, April 6, 2026, 17:30 Hrs [IST] Akebia Therapeutics ...
Pharmabiz

Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions

Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions: Ta ...
Pharmabiz

Jan Vishwas (Amendment of Provisions) Bill, 2026 brings in key legislations in Drugs and Cosmetics Act and Pharmacy Act

Bill, 2026 brings in key legislations in Drugs and Cosmetics Act and Pharmacy Act: Our Bureau, New Delhi Monday, April 6, 2026, 15:30 Hrs [IS ...
Pharmabiz

Alpha Cognition receives US patent for ALPHA-1062 for treatment of traumatic brain injury

Alpha Cognition receives US patent for ALPHA-1062 for treatment of traumatic brain injury: Vancouver, British Columbia Monday, April 6, 2026, 16:00 Hrs [IST] Alpha Cognition Inc, ...
Pharmabiz

WHO updates guidelines on opioid dependence treatment and overdose prevention

WHO updates guidelines on opioid dependence treatment and overdose prevention: Geneva Monday, April 6, 2026, 14:00 Hrs [IST] WHO announces the update of several recommendations in ...
Pharmabiz

OneCyte and Kemp Proteins partner to accelerate high-performance cell line development for next-generation biologics

OneCyte and Kemp Proteins partner to accelerate high-performance cell line development for next-generation biologics: Cambridge, Massachusetts Monday, April 6, 2026, 12:00 Hrs [IS ...
Pharmabiz

DoP organises webinar on AI-driven innovations

Our Bureau, New Delhi Monday, April 6, 2026, 14:15 Hrs [IST] The Department of Pharmaceuticals (DoP) organised a webinar on “AI a ...